Literature DB >> 9230791

Whole blood chloroquine concentrations with Plasmodium vivax infection in Irian Jaya, Indonesia.

J K Baird1, B Leksana, S Masbar, M A Sutanihardja, D J Fryauff, B Subianto.   

Abstract

Whole blood concentrations of self-administered chloroquine (CQ) and its metabolite desethylchloroquine (DCQ) were measured in 168 patients with microscopically confirmed infection by Plasmodium vivax in northeastern Irian Jaya, Indonesia. The study consisted of both survey and passive case detection in four separate villages between 1992 and 1994. The subjects were Javanese people 4-51 years old who had lived in the Arso region for up to two years. The sum of CQ and DCQ ranged from 0 to 8,342 ng/ml of whole blood, and 122 subjects (73%) had > or = 100 ng/ml of CQ plus DCQ, the estimated minimally effective concentration (MEC) in whole blood against chloroquine-sensitive P. vivax. Among 56 subjects reporting to a clinic with symptoms of malaria, 53 (95%) had ordinarily effective levels of chloroquine in blood. Among 109 largely asymptomatic malaria patients found by survey case detection, 69 (63%) had chloroquine blood levels greater than the MEC. Virtually all clinical and most subclinical vivax malaria in this region occurs despite ordinarily effective levels of chloroquine in blood.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9230791     DOI: 10.4269/ajtmh.1997.56.618

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  6 in total

Review 1.  Chloroquine resistance in Plasmodium vivax.

Authors:  J Kevin Baird
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

Review 2.  Resurgent malaria at the millennium: control strategies in crisis.

Authors:  J K Baird
Journal:  Drugs       Date:  2000-04       Impact factor: 9.546

Review 3.  Malaria distribution, prevalence, drug resistance and control in Indonesia.

Authors:  Iqbal R F Elyazar; Simon I Hay; J Kevin Baird
Journal:  Adv Parasitol       Date:  2011       Impact factor: 3.870

Review 4.  Efficacy and safety of artemisinin combination therapy (ACT) for non-falciparum malaria: a systematic review.

Authors:  Benjamin J Visser; Rosanne W Wieten; Daniëlle Kroon; Ingeborg M Nagel; Sabine Bélard; Michèle van Vugt; Martin P Grobusch
Journal:  Malar J       Date:  2014-11-26       Impact factor: 2.979

Review 5.  Management of relapsing Plasmodium vivax malaria.

Authors:  Cindy S Chu; Nicholas J White
Journal:  Expert Rev Anti Infect Ther       Date:  2016-08-31       Impact factor: 5.091

6.  In vivo efficacy of artemether-lumefantrine and chloroquine against Plasmodium vivax: a randomized open label trial in central Ethiopia.

Authors:  Jimee Hwang; Bereket Hailegiorgis Alemayehu; Richard Reithinger; Samuel Girma Tekleyohannes; Sintayehu Gebresillasie Birhanu; Leykun Demeke; David Hoos; Zenebe Melaku; Moges Kassa; Daddi Jima; Joseph L Malone; Henry Nettey; Michael Green; Amanda Poe; Sheila Akinyi; Venkatachalam Udhayakumar; S Patrick Kachur; Scott Filler
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.